Screener
Wave Life Sciences WVE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 51,293 | 43,469 | 98,733 | 84,091 |
| General and administrative | 24,781 | 17,989 | 46,884 | 36,346 |
| Total operating expenses | 76,074 | 61,458 | 145,617 | 120,437 |
| Loss from operations | (73,802) | (52,759) | (105,099) | (102,563) |
| Other income, net: | ||||
| Interest income | 4,722 | 2,372 | 10,013 | 5,247 |
| Other expense | (275) | (82) | (356) | (31) |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's total operating expenses?
- Wave Life Sciences (WVE) reported total operating expenses of $76.07M in Q2 2026.
- How has Wave Life Sciences's total operating expenses changed year-over-year?
- Wave Life Sciences's total operating expenses increased by 23.8% year-over-year, from $61.46M to $76.07M.
- What is the long-term trend for Wave Life Sciences's total operating expenses?
- Over 4 years (2021 to 2025), Wave Life Sciences's total operating expenses has grown at a 11.3% compound annual growth rate (CAGR), from $167.98M to $258.11M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Wave Life Sciences's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude